| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 02/03/2011 | US20110027303 Partial peptide of survivin presented on mhc class ii molecule and use therof |
| 02/03/2011 | US20110027302 Peptide vaccines for lung cancers expressing ttk, urlc10 or koc1 polypeptides |
| 02/03/2011 | US20110027301 Ex-vivo priming for generating cytotoxic t lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease |
| 02/03/2011 | US20110027300 Identification of a novel cysteine-rich cell penetrating peptide |
| 02/03/2011 | US20110027299 Melanoma antigens and their use in diagnostic and therapeutic methods |
| 02/03/2011 | US20110027298 Microbial delivery system |
| 02/03/2011 | US20110027297 Methods Involving MS4A12 and Agents Targeting MS4A12 for Therapy, Diagnosis and Testing |
| 02/03/2011 | US20110027296 Antibodies for treating cancer |
| 02/03/2011 | US20110027295 Adenosine Receptor Agonists and Antagonists to Modulate T Cell Responses |
| 02/03/2011 | US20110027294 Anti-Respiratory Syncytial Virus Antibodies, Antigens and Uses Thereof |
| 02/03/2011 | US20110027293 Methods and compositions for the inhibition of viral infection by targeting intracellular trafficking |
| 02/03/2011 | US20110027292 Protein Formulations with Reduced Viscosity and Uses Thereof |
| 02/03/2011 | US20110027291 Methods, systems and products for predicting response of tumor cells to a therapeutic agent and treating a patient according to the predicted response |
| 02/03/2011 | US20110027290 Anti-il-17 antibodies |
| 02/03/2011 | US20110027289 Method for treating synovial sarcoma |
| 02/03/2011 | US20110027288 Human monoclonal antibodies against amyloid beta protein, and their use as therapeutic agents |
| 02/03/2011 | US20110027287 Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (pcsk9) |
| 02/03/2011 | US20110027286 High Affinity Human Antibodies to Human Angiopoietin-2 |
| 02/03/2011 | US20110027285 Methods and agents modulating upa/upar activity |
| 02/03/2011 | US20110027284 Nogo-a binding molecules and pharmaceutical use thereof |
| 02/03/2011 | US20110027283 Methods for diagnosing and treating cancers |
| 02/03/2011 | US20110027282 Interferon antagonists, antibodies thereto and associated methods of use |
| 02/03/2011 | US20110027281 Single domain antibodies directed against tumor necrosis factor-alpha and uses therefor |
| 02/03/2011 | US20110027280 Methods For Inducing Autolysis In Infectious Bacteria |
| 02/03/2011 | US20110027279 Recombinant antibodies specific for beta-amyloid ends, dna encoding and methods of use thereof |
| 02/03/2011 | US20110027278 Regulatory t cell mediator proteins and uses thereof |
| 02/03/2011 | US20110027277 Predictive marker for topoisomerase i inhibitors |
| 02/03/2011 | US20110027276 Optimized CD40 Antibodies and Methods of Using the Same |
| 02/03/2011 | US20110027275 Inhibition of tumor metastasis |
| 02/03/2011 | US20110027274 Antiproliferative compounds, conjugates thereof, methods therefor, and uses thereof |
| 02/03/2011 | US20110027273 Immunotherapy of autoimmune disorders |
| 02/03/2011 | US20110027272 Stabilized liquid anti-rsv antibody formulations |
| 02/03/2011 | US20110027271 Antibody composition exhibiting cellular cytotoxicty due to glycosylation |
| 02/03/2011 | US20110027270 Monoclonal antibodies against influenza virus generated by cyclical administration and uses thereof |
| 02/03/2011 | US20110027269 14-3-3 Antagonists for the Prevention and Treatment of Arthritis |
| 02/03/2011 | US20110027268 Anti-mesothelin antibodies and uses thereof |
| 02/03/2011 | US20110027267 Fusion Proteins of Mannose Binding Lectins for Treatment of Disease |
| 02/03/2011 | US20110027266 Humanized anti-CXCR5 antibodies, derivatives thereof and their use |
| 02/03/2011 | US20110027265 Methods and Compositions Related to Immunizing Against Staphylococcal Lung Diseases and Conditions |
| 02/03/2011 | US20110027264 Gamma secretase modulators for the treatment of alzheimer's disease |
| 02/03/2011 | US20110027263 Soluble interleukin-20 receptor |
| 02/03/2011 | US20110027262 Platform antibody compositions |
| 02/03/2011 | US20110027261 Anti-hepcidin antibodies and uses thereof |
| 02/03/2011 | US20110027260 Bcl-g polypeptides, encoding nucleic acids and methods of use |
| 02/03/2011 | US20110027259 Component of bromelain |
| 02/03/2011 | US20110027227 Antiviral drugs for treatment of arenavirus infection |
| 02/03/2011 | US20110027226 Indolopyridines as inhibitors of the kinesin spindle protein (eg5) |
| 02/03/2011 | US20110027225 MN/CA IX and EGFR Pathway Inhibition |
| 02/03/2011 | US20110027222 Vaccine for the Treatment of Osteoarthritis |
| 02/03/2011 | US20110027220 Interleukin-1 Conjugates and Uses Thereof |
| 02/03/2011 | US20110027190 Composition of a first non-labeled monoclonal antibody binding to a tumor antigen and a non-cross reactive second monoclonal antibody labeled with a nir fluorescence label |
| 02/03/2011 | US20110027188 Methods, Compositions and Devices for Treating Lesioned Sites Using Bioabsorbable Carriers |
| 02/03/2011 | US20110027186 Taz/wwtr1 for diagnosis and treatment of cancer |
| 02/03/2011 | US20110027185 Methods of Screening for Anti-Angiogenic Compounds |
| 02/03/2011 | US20110027183 Hydrophobic Modified Pres-Derived Peptides of Hepatitis B Virus (HBV) and Their Use as Vehicles for the Specific Delivery of Compounds to the Liver |
| 02/03/2011 | US20110027182 Substance for obtaining highly effective tumor medications as well as a process |
| 02/03/2011 | US20110027180 Detection and treatment of prostate cancer |
| 02/03/2011 | US20110027177 Inhibition of angiogenesis |
| 02/03/2011 | US20110027173 Ephrin type-a receptor 10 protein |
| 02/03/2011 | US20110027171 Ph sensitive liposome composition |
| 02/03/2011 | CA2769752A1 Adenoviral-based vectors |
| 02/03/2011 | CA2769673A1 Reverse genetics systems |
| 02/03/2011 | CA2769645A1 Polymer particles and uses thereof |
| 02/03/2011 | CA2769518A1 Dual variable domain immunoglobulins and uses thereof |
| 02/03/2011 | CA2769473A1 Fully human antibodies to btla |
| 02/03/2011 | CA2769334A1 High affinity human antibodies to human angiopoietin-2 |
| 02/03/2011 | CA2769308A1 Inhibition of tumor metastasis using bv8- or g-csf-antagonists |
| 02/03/2011 | CA2769223A1 Sticky soft gel for treating poultry |
| 02/03/2011 | CA2769011A1 Vaccine stabilizer |
| 02/03/2011 | CA2768997A1 High yield yellow fever virus strain with increased propagation in cells |
| 02/03/2011 | CA2768887A1 Orf7 deficient varicella virus, vaccine comprising the virus and use thereof |
| 02/03/2011 | CA2768552A1 Programming of cells for tolerogenic therapies |
| 02/03/2011 | CA2768346A1 Antigenic tau peptides and uses thereof |
| 02/03/2011 | CA2762366A1 H. pylori lipopolysaccharide outer core epitope |
| 02/02/2011 | EP2280082A2 Identification of surface-associated antigenes used for the diagnosis and therapy of tumours |
| 02/02/2011 | EP2280074A2 Polynucleotides encoding antigenic HIV type B and/or type C polypeptides, polypeptides and uses thereof |
| 02/02/2011 | EP2280073A2 Vaccine for prevention and treatment of HIV-infection |
| 02/02/2011 | EP2280072A2 Group B streptococcus antigens |
| 02/02/2011 | EP2280071A2 Haemophilus influenzae antigens and corresponding DNA fragments |
| 02/02/2011 | EP2280066A2 Recombinant Clostridium neurotoxin fragments |
| 02/02/2011 | EP2280031A1 Cancer antigens based on products of the tumor suppressor gene WT1 |
| 02/02/2011 | EP2280030A2 Nucleic acids and corresponding proteins useful in the detection and treatment of various cancers |
| 02/02/2011 | EP2279755A2 Remodelling and glycoconjugation of Fibroblast Growth Factor (FGF) |
| 02/02/2011 | EP2279754A2 Remodelling and glycoconjugation of human growth hormone (hGH) |
| 02/02/2011 | EP2279753A2 Remodeling and glycoconjugation of peptides |
| 02/02/2011 | EP2279749A1 Binding molecules for treatment and detection of cancer |
| 02/02/2011 | EP2279748A1 Multivalent vaccine composition |
| 02/02/2011 | EP2279747A1 Immunogenic bacterial vesicles with outer membrane proteins |
| 02/02/2011 | EP2279746A2 Surface proteins in neisseria meningitidis |
| 02/02/2011 | EP2279246A2 Methods and compositions for modulating immunological tolerance |
| 02/02/2011 | EP2279203A2 Prion epitopes and methods of use thereof |
| 02/02/2011 | EP2279004A2 Use of biomarkers for assessing treatment of gastrointestinal inflammatory disorders with beta7integrin antagonists |
| 02/02/2011 | EP2279003A2 An anti-cd137 antibody as an agent in the treatment of inflammatory conditions |
| 02/02/2011 | EP2279002A2 Anti-nucleic acid antibody inducing cell death of cancer cells and composition for preventing or treating cancers comprising the same |
| 02/02/2011 | EP2279001A1 Inhibitors of gm-csf and il-17 for therapy |
| 02/02/2011 | EP2279000A1 Method for the prevention and treatment of cancer by inhibition of gpvi |
| 02/02/2011 | EP2278999A2 Auris formulations for treating otic diseases and conditions |
| 02/02/2011 | EP2278998A1 Design and synthesis of directed sequence polymer compositions and antibodies thereof for the treatment of protein conformational disorders |
| 02/02/2011 | EP2278997A1 Nanoemulsion influenza vaccine |
| 02/02/2011 | EP2278996A1 Adjuvants for use in vaccination |